7th Annual New Therapeutics in Oncology: The Road to Personalized Medicine
In-Person Event
Nov 09 - 10, 2018
Los Angeles, California, USA
OVERVIEW
7th Annual New Therapeutics in Oncology: The Road to Personalized Medicine is organized by Cedars-Sinai Medical Center and will be held from Nov 09 - 10, 2018 at Cedars Sinai Medical Center Harvey Morse Conference Center South Tower, Los Angeles, California, United States of America.
The target audience for this medical event is oncology clinicians, oncology nurses, physicians, pharmacists, nurse practitioners, physician assistants, and pharmacists. This CME Conference has been approved for a maximum of 8.0 AMA PRA Category 1 Credits.
Overview:
This conference provides the audience with the most current information available about new agents in oncology and the translation of the latest research to their patients.
The conference will cover drug and treatment updates with a focus on new agents in breast cancer, gynecological malignancies, lung cancer, and GI tumors. The conference also features a mini-symposia that will address evolving paradigms for the treatment of GU tumors, including renal cancer, bladder cancer, and diet and lifestyle interventions in and expert management of prostate cancer in 2018.
Objectives:
• Utilize AJCC or another appropriate staging in clinical practice, including appropriate prognostic indicators and evidence-based national guidelines for treatment planning
• Evaluate clinical data and mechanism of action for newly approved drugs for the treatment of cancer
• Assess cancer immunotherapy treatments and their application in clinical practice based on the mechanism of action, side effects, and indications for use
• Discuss the latest updates and options for the treatment of gynecological malignancies and the integration of new therapies for breast cancer
• Evaluate emerging clinical data for new agents and evolving strategies for the treatment of various types of cancer and develop individualized treatment plans for patients based on an evaluation of efficacy and safety
• Explore evolving paradigms and advances for the treatment of genitourinary (GU) tumors, including renal cancer sequencing strategies, integration of newly approved agents, and diet and lifestyle interventions for prostate cancer
• Assess treatment paradigms for sarcoma and rare tumors and their application in practice
Additional details will be posted as soon as they are available.
The target audience for this medical event is oncology clinicians, oncology nurses, physicians, pharmacists, nurse practitioners, physician assistants, and pharmacists. This CME Conference has been approved for a maximum of 8.0 AMA PRA Category 1 Credits.
Overview:
This conference provides the audience with the most current information available about new agents in oncology and the translation of the latest research to their patients.
The conference will cover drug and treatment updates with a focus on new agents in breast cancer, gynecological malignancies, lung cancer, and GI tumors. The conference also features a mini-symposia that will address evolving paradigms for the treatment of GU tumors, including renal cancer, bladder cancer, and diet and lifestyle interventions in and expert management of prostate cancer in 2018.
Objectives:
• Utilize AJCC or another appropriate staging in clinical practice, including appropriate prognostic indicators and evidence-based national guidelines for treatment planning
• Evaluate clinical data and mechanism of action for newly approved drugs for the treatment of cancer
• Assess cancer immunotherapy treatments and their application in clinical practice based on the mechanism of action, side effects, and indications for use
• Discuss the latest updates and options for the treatment of gynecological malignancies and the integration of new therapies for breast cancer
• Evaluate emerging clinical data for new agents and evolving strategies for the treatment of various types of cancer and develop individualized treatment plans for patients based on an evaluation of efficacy and safety
• Explore evolving paradigms and advances for the treatment of genitourinary (GU) tumors, including renal cancer sequencing strategies, integration of newly approved agents, and diet and lifestyle interventions for prostate cancer
• Assess treatment paradigms for sarcoma and rare tumors and their application in practice
Additional details will be posted as soon as they are available.
KEY DATES
09 Nov, 2018
Event Start Date
10 Nov, 2018
Event End Date
SPECIALITIES
OncologyFamily MedicineInternal Medicine and General MedicineSUGGESTED HOTELS
CONFERENCE VENUE
Cedars Sinai Medical Center Harvey Morse Conference Center South TowerRELATED CONFERENCES & LIVE WEBINARS
Quick Links